Michael Gelband’s Treace Medical Concepts TMCI Stock Holding History

Michael Gelband’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Buy	+53,156	New	+$146K	﹤0.01%	1419
2025 Q2	–	Sell	-27,893	Closed	-$234K	–	1973
2025 Q1	$234K	Sell	27,893 -5,828	-17%	-$52.4K	﹤0.01%	1272
2024 Q4	$251K	Buy	+33,721	New	+$226K	﹤0.01%	1324
2024 Q2	–	Sell	-55,498	Closed	-$724K	–	1983
2024 Q1	$724K	Buy	+55,498	New	+$740K	0.01%	1047
2023 Q3	–	Sell	-15,543	Closed	-$398K	–	2142
2023 Q2	$398K	Buy	15,543 +376	+2%	+$9.71K	﹤0.01%	1439
2023 Q1	$382K	Buy	+15,167	New	+$356K	﹤0.01%	1409

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Michael Gelband's TMCI Position: Q2 2026 in Review

Michael Gelband opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 53,156 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1419 among its holdings. This is a return to the name: Michael Gelband previously reported a position in TMCI as recently as Q1 2025.

Michael Gelband first reported a position in TMCI in Q1 2023 and has held it in 6 quarters since. The position peaked at $724K in Q1 2024. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

Michael Gelband held 53,156 shares of Treace Medical Concepts worth $212K as of Q2 2026.
Treace Medical Concepts was a new Michael Gelband position in Q2 2026.
Treace Medical Concepts made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1419 holding.
Michael Gelband first reported a position in Treace Medical Concepts in Q1 2023 and has held it in 6 quarters since.
Michael Gelband's Treace Medical Concepts position peaked at $724K in Q1 2024.
117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.